Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 463
Selected: 0
NCT IDTitle
NCT02449343Study of Anlotinib in Patients With Soft Tissue Sarcoma(STS)(ALTER0203)
NCT04007835Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI
NCT07003074A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer
NCT01924195Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer(ALTER0302)
NCT04236362A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer
NCT04306887A Study of TQ-B3101 in Subjects With Relapsed or Refractory Anaplastic Large Cell Lymphoma (ALCL)
NCT07252908A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder
NCT06230588A Clinical Trial of TQH3906 Capsules in Healthy Volunteers
NCT06116240A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors
NCT07551427A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk Myelofibrosis
NCT04610970A Study of TQ-B3525 in Subjects With Relapse/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
NCT07529925A Clinical Trail of Adalimumab in Treating Chinese Children With Severe Plaque Psoriasis
NCT07293390A Clinical Trial of Mass Balance of [14C] TQ05105 in Healthy Chinese Subjects
NCT07179679A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors
NCT05998941A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer
NCT06725641Bioequivalence Study of Methacholine for Inhalation (pharmacodynamics)
NCT07622667Correlation Analysis of Gene Characteristics of Malignant Tumors With Prognosis
NCT06962267A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)
NCT05815862Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer
NCT03847246Bioequivalence Study of Entecavir Tablets and Baraclude® Under Fasting Condition in Chinese Healthy Volunteers
NCT07367529A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
NCT05496569TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma
NCT06008405Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy
NCT04144855A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3474 Injection
NCT01937832A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia
NCT07172126Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets
NCT03777085Study of TQB2303 in Patients With CD20-Positive Diffuse Large B-cell Lymphoma (DLBCL)
NCT05046847A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3811 Tablets in Patients With Advanced Malignant Tumors
NCT02332499Study of Anlotinib in Patients With Metastatic Colorectal Cancer(mCRC)(ALTER0703)
NCT04925141A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)
NCT03735264Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer(ALTER-L034)
NCT03983928Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer
NCT06222944Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA
NCT07367516Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer
NCT04061109Safety, Efficacy Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.
NCT03461627Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma
NCT06851442Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
NCT05987358A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.
NCT07730190A Clinical Trial of TQB6426 for Injection in Patients With Advanced Solid Tumors
NCT04808570A Study of TQ-B3525 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT05198531To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal Cancer
NCT03601975Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma
NCT07797231Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response
NCT05032937the Accuracy and Safety of Coronary Artery Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle
NCT05576480SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer
NCT01795716Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body
NCT04326348A Study of TQ05105 Tablets in Subjects With Hemophagocytic Lymphohistiocytosis(HLH)
NCT02779699A Study of AL2846 on Tolerance and Pharmacokinetics
NCT04569838A Study to Evaluate the Efficacy and Safety of Bendamustine Hydrochloride Injection
NCT07545213Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis